Data monetisation drives Sanofi investment in Owkin

Sanofi’s $180 million investment in AI biotech Owkin is the latest of several recent developments suggesting that barriers to the vast commercial potential of healthcare data are about to be torn down.


Get unlimited access to all Global Data Review content